Unlicensed Medicines Expansion IPS Pharma’s strength in unlicensed medicines, specials, and 20,000+ formulations presents a clear sales opportunity to expand into new markets or clinics seeking compliant, diverse compounding capabilities and reliable supply for niche therapies.

Clinical Trial Support The company provides Investigational Medical Products and trial comparators, suggesting potential partnerships with CROs, research institutions, and biotechs in need of validated IMP sourcing and trial-ready materials.

Global Sourcing Network IPS Pharma’s established global supplier network underscores opportunities to offer end-to-end procurement services, supplier vetting, and logistics optimization for multinational pharma teams seeking consistent quality across regions.

Regulatory Trust MHRA licensing and APSM membership signal strong compliance credibility, enabling outreach to regulated med-tech and hospital procurement teams prioritizing quality assurance and ethical sourcing in unlicensed and special products.

Strategic Collaborations Past partnerships (Avicanna licensing, Grow Group JV) indicate a receptiveness to collaboration; target co-development, distribution, or JV discussions with mid-sized pharma players seeking flexible supply and market entry support.